D.E. Castellano Gauna

LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)

Thomas Powles, Begoña P. Valderrama, Shilpa Gupta et al. · Annals of Oncology · 2023 · 131 citations · Full text

Urology, Genitourinary Cancer, Medicine +6

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 102 citations · Full text

LBA13 Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)

Oliver Sartor, D.E. Castellano Gauna, Ken Herrmann et al. · Annals of Oncology · 2023 · 66 citations · Full text

Urology, Genitourinary Cancer, Medicine +6

LBA75 Prospective randomised phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer: Results of the SUNNIFORECAST trial

Lars Bergmann, Marit Ahrens, L. Albiges et al. · Annals of Oncology · 2024 · 18 citations · Full text

Renal Care, Urology, Genitourinary Cancer +7